3-Fluoro-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

4-(6-Chloro-3-pyridazinyl)morpholine, 95.0%, 25g

4,4,5,5-Tetramethyl-2-(spiro[fluorene-9,9'-xanthen]-4-yl)-1,3,2-dioxaborolane, 98%, 250mg

1-(3,5-dinitrobenzoyl)-2-methylpiperazine, 95.0%, 5g

7-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98+%, 500mg

Diphenyl[4-(phenylthio)phenyl]sulfonium Hexafluoroantimonate>98.0%(HPLC)1g

6,8-difluoro-2-methyl-1,4-dihydroquinolin-4-one, 95%, 10g

3-Chloro-7H-pyrrolo[2,3-c]pyridazine, 95.0%, 10g

methyl (1S,4R)-4-aminocyclopent-2-ene-1-carboxylate hydrochloride, 98%, 1g

Ethyl 1-methyl-2-oxocyclohexane-1-carboxylate, 98%, 250mg

2,6-Dichloroquinoline-4-carbonitrile, 98%, 1g

4-methyl-2-oxo-2H-chromene-3-carboxylic acid, 95.0%, 1g

2-Bromo-6-fluoro-4-hydroxy-benzaldehyde, 96%, 1g